← Leaderboards
Rong Zhou
University Of Pennsylvania
$5,743,610
Attributed
$9,757,059
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2006–25$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,757,059 · 6
By mechanism
R01$5,986,710 · 3
U24$2,951,674 · 1
R21$818,675 · 2
Top collaborators
- David A Mankoff9 shared
- Peter J O'Dwyer5 shared
- Mark Alan Rosen5 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- David Tuveson$22,023,736
- Lewis A Chodosh$38,386,361
- Gregory L Beatty$6,306,069
- David A Mankoff$17,196,499
- Angela Demichele$6,304,623
Others in their field
Top investigators on “Response”
- Lawrence Corey · Fred Hutchinson Cancer Center$677,505,141
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$532,027,174
- Barton F Haynes · Duke University$497,761,007
- Jeffrey P Krischer · University Of South Florida$397,532,270
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
Research focus
ResponseImaging ModalityMalignant NeoplasmsClinicCellsImaging BiomarkerTumorImageBaseModalityClinical TrialsResistanceVariantPositron-Emission TomographyGlutamatesPredictive MarkerGlutaminaseProductionMetabolismAnabolismMalignant Breast NeoplasmPathway InteractionsGlutamineAmino Acids
Grant awards (23)
PET Imaging of Glutamine Metabolism and Glutamate Transport to Guide Metabolically Targeted Therapy in Triple-Negative Breast Cancer$522,750
R01 · FY2025 · CA
PET Imaging of Glutamine Metabolism and Glutamate Transport to Guide Metabolically Targeted Therapy in Triple-Negative Breast Cancer$496,614
R01 · FY2024 · CA
PET Imaging of Glutamine Metabolism and Glutamate Transport to Guide Metabolically Targeted Therapy in Triple-Negative Breast Cancer$517,072
R01 · FY2023 · CA
Penn Quantitative MRI Resource for Pancreatic Cancer$574,949
U24 · FY2022 · CA · contact PI
PET Imaging of Glutamine Metabolism and Glutamate Transport to Guide Metabolically Targeted Therapy in Triple-Negative Breast Cancer$562,902
R01 · FY2022 · CA
Penn Quantitative MRI Resource for Pancreatic Cancer$607,181
U24 · FY2021 · CA · contact PI
Molecular Imaging Markers for Glutaminolysis in Breast Cancer$402,259
R01 · FY2021 · CA
Penn Quantitative MRI Resource for Pancreatic Cancer$607,181
U24 · FY2020 · CA · contact PI
Molecular Imaging Markers for Glutaminolysis in Breast Cancer$402,259
R01 · FY2020 · CA
Penn Quantitative MRI Resource for Pancreatic Cancer$588,964
U24 · FY2019 · CA · contact PI
Molecular Imaging Markers for Glutaminolysis in Breast Cancer$390,191
R01 · FY2019 · CA
Penn Quantitative MRI Resource for Pancreatic Cancer$573,399
U24 · FY2018 · CA · contact PI
Molecular Imaging Markers for Glutaminolysis in Breast Cancer$382,319
R01 · FY2018 · CA
Molecular Imaging Markers for Glutaminolysis in Breast Cancer$414,966
R01 · FY2017 · CA
Metabolic Imaging Marker for Triple Negative Breast Cancer$208,800
R21 · FY2016 · CA · contact PI
Metabolic Imaging Marker for Triple Negative Breast Cancer$174,000
R21 · FY2015 · CA · contact PI
Imaging Stem Cell Grafted in the Infarcted Myocardium$436,568
R01 · FY2009 · HL · contact PI
Imaging Stem Cell Grafted in the Infarcted Myocardium$196,269
R01 · FY2009 · HL · contact PI
Imaging Stem Cell Grafted in the Infarcted Myocardium$417,476
R01 · FY2008 · HL · contact PI
Imaging Stem Cell Grafted in the Infarcted Myocardium$415,405
R01 · FY2007 · HL · contact PI
Imaging Stem Cell Grafted in the Infarcted Myocardium$429,660
R01 · FY2006 · HL · contact PI
Assessment of Stem Cell Therapy of Infarcted Myocardium$198,125
R21 · FY2004 · EB
Assessment of Stem Cell Therapy of Infarcted Myocardium$237,750
R21 · FY2003 · EB